Effects of berberine on cholesterol metabolism and Insig-2 gene expression of hyperlipidemic rats

Chinese Pharmacological Bulletin

Volumn 25, Issue 1, 2009, Pages 85-88

  Chang, Wei ^a   Wang, Hong ^a   Yin, Hua Feng ^a   Zhou, Qi Xin ^a   Yang, Jun Xia ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Berberine; Gene expression; Hypolipidemic; Insig 2

Indexed keywords

BERBERINE; CHOLESTEROL; GENE PRODUCT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN INDUCED GENE 2 PROTEIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MEVINOLIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG MEGADOSE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; LOW DRUG DOSE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 64549118706     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Zhou L B, Chen M D, Wang X, et al. Effects of berberine on the differentiation of adipocyte[J]. Natl Med J China,2003,83(4): 338-40.
2. Wang C B, Lu F E, Leng S H, et al. Effects of berberine on the activity of glucokinase and the gene expression in cultured hepG2 cells[J]. Chin Pharmacol Bull,2007,23(9):1145-7.
3. Iizuka N, Hazama S, Yoshimura K, et al. Anticachectic effects of the natural herb Coptidis rhizoma and herberine on mice bearing colon 26/ clone 20 adenocarcinoma [J]. Int J Cancer, 2002, 99 (2):286-91.
4. Kuo C L, Chi C W, Liu T Y. The anti-inflammatory potential of berberine in vitro and in vivo[J]. Cancer Lett,2004,203(2):127-37.
5. Yabe D, Brown M S, Goldstein J L. Insig-2, a second endoplasmIc reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins [J]. Proc Natl Acad Sci USA, 2002,99(20):12753-8.
6. Zhang D, Wu H J, Chen S P, et al. Comparison of the five models on experimental hyperlipidemia rats [J]. Chin Pharmacol Bull, 2007, 23(9):1254-6.
7. Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-low-ering drug working through a unique mechanism distinct from statins[J]. Nat Med,2004,10(12):1344-51.
8. Abidi P, Zhou Y, Jiang J D, et al. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine [J]. Arterioscler Thromb Vase Biol,2005,25(10):2170-6.
9. Hubbert M L, Zhang Y, Lee F Y, et al. Regulation of hepatic Insig-2 by the farnesoid X receptor[J]. Mol Endocrinol,2007,21(6): 1359-69.
10. Krapivner S, Popov S, Chemogubova E, et al. Insulin-induced gene 2 (INSIG2) involvement in human adipocyte metabolism and body weight regulation[J]. J Clin Endocrinol Metab,2008,93(5):1995-2001.
11. Xie Y H, Mo Z H, Chen K, et al. Effect of different glucose concentrations on the expressions of insig-1 and insig-2 mRNA during the differentiation of 3T3-L cells[J]. Zhong Nan Da Xue Xue Bao(Yi Xue Ban),2008,33(3):238-44.
12. Sever N, Song B L, Yabe D, et al. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol [J]. J Biol Chem,2003, 278,(52):52479-90.